Tag: rate

[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global GLP-1 Receptor Agonist Market size & share revenue was valued at approximately USD 28.7 Billion in 2025 and is expected to reach USD 34.2 Billion in 2026 and is expected to reach around USD 95.3 Billion by 2035, at a CAGR of 12.1% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., AstraZeneca plc, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Pfizer Inc., Merck & Co. Inc., Zealand Pharma A/S, Hanmi Pharmaceutical Co. Ltd. and others.

Not for distribution to U.S. newswire services nor for dissemination to the United States. 
All amounts in Canadian dollars.

Alongside, by TimelyCare, analyzes 1 million+ student interactions to reveal critical trends in belonging, motivation, and attendance

Miami, Florida, June 16, 2026 (GLOBE NEWSWIRE) --

There is a quiet conversation happening in fitting rooms, group texts, and medical offices all over the country that rarely surfaces publicly. It is about arms. More specifically, it is about the moment a woman picks up a sleeveless top, holds it against herself in the mirror, and puts it back on the rack. Not because the top is the wrong color or cut. Because she does not want her arms on display.

Operational Highlights May

EfTEN United Property Fund earned a net profit of 109 thousand euros in May, and 812 thousand euros over the first five months of 2026 (compared to 1 322 thousand euros in the same period last year). In May, the fund decided to make a cash distribution to investors in the amount of 1,060 thousand euros, or 42.676 euro cents per unit. As a result, the net asset value (NAV) per fund unit decreased by 3,2% and stood at 11,66 euros at the end of May. Without the distribution, the NAV of EfTEN United Property Fund would have grown by 0,4% over the month.